{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:29:43Z","timestamp":1793982583475,"version":"4.8.0"},"reference-count":353,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Russian Science Foundation","award":["22-15-00409"],"award-info":[{"award-number":["22-15-00409"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Hemolytic uremic syndrome (HUS) is an acute disease and the most common cause of childhood acute renal failure. HUS is characterized by a triad of symptoms: microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. In most of the cases, HUS occurs as a result of infection caused by Shiga toxin-producing microbes: hemorrhagic Escherichia coli and Shigella dysenteriae type 1. They account for up to 90% of all cases of HUS. The remaining 10% of cases grouped under the general term atypical HUS represent a heterogeneous group of diseases with similar clinical signs. Emerging evidence suggests that in addition to E. coli and S. dysenteriae type 1, a variety of bacterial and viral infections can cause the development of HUS. In particular, infectious diseases act as the main cause of aHUS recurrence. The pathogenesis of most cases of atypical HUS is based on congenital or acquired defects of complement system. This review presents summarized data from recent studies, suggesting that complement dysregulation is a key pathogenetic factor in various types of infection-induced HUS. Separate links in the complement system are considered, the damage of which during bacterial and viral infections can lead to complement hyperactivation following by microvascular endothelial injury and development of acute renal failure.<\/jats:p>","DOI":"10.3390\/biom14010039","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T05:43:15Z","timestamp":1703655795000},"page":"39","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome"],"prefix":"10.3390","volume":"14","author":[{"given":"Piotr P.","family":"Avdonin","sequence":"first","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Blinova","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina A.","family":"Generalova","sequence":"additional","affiliation":[{"name":"Saint Vladimir Moscow City Children\u2019s Clinical Hospital, 107014 Moscow, Russia"},{"name":"Department of Pediatrics, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadizha M.","family":"Emirova","sequence":"additional","affiliation":[{"name":"Saint Vladimir Moscow City Children\u2019s Clinical Hospital, 107014 Moscow, Russia"},{"name":"Department of Pediatrics, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4138-1589","authenticated-orcid":false,"given":"Pavel V.","family":"Avdonin","sequence":"additional","affiliation":[{"name":"Koltzov Institute of Developmental Biology RAS, ul. Vavilova, 26, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/ckj\/sfz040","article-title":"An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy","volume":"12","author":"Aigner","year":"2019","journal-title":"Clin. Kidney J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood.2020009280","article-title":"Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: A prospective multicenter study","volume":"137","author":"Fakhouri","year":"2021","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101341","DOI":"10.1016\/j.smim.2019.101341","article-title":"Regulation of regulators: Role of the complement factor h-related proteins","volume":"45","author":"Cserhalmi","year":"2019","journal-title":"Semin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.152.9.4624","article-title":"Complement component c7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human c7","volume":"152","author":"Wurzner","year":"1994","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.immunol.16.1.545","article-title":"The role of complement and complement receptors in induction and regulation of immunity","volume":"16","author":"Carroll","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2017.05.012","article-title":"Intracellular complement\u2014The complosome\u2014In immune cell regulation","volume":"89","author":"Arbore","year":"2017","journal-title":"Mol. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.4049\/jimmunol.136.8.2999","article-title":"C5b-9 assembly: Average binding of one c9 molecule to c5b-8 without poly-c9 formation generates a stable transmembrane pore","volume":"136","author":"Bhakdi","year":"1986","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1084\/jem.156.1.268","article-title":"Molecular organization of c9 within the membrane attack complex of complement. Induction of circular c9 polymerization by the c5b-8 assembly","volume":"156","author":"Podack","year":"1982","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4049\/jimmunol.102.1.93","article-title":"A neutrophil chemotactic factor from human c\u20325","volume":"102","author":"Ward","year":"1969","journal-title":"J. Immunol."},{"key":"ref_14","first-page":"120","article-title":"Role of complement and other innate immune mechanisms in the removal of apoptotic cells","volume":"9","author":"Ogden","year":"2006","journal-title":"Curr. Dir. Autoimmun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"599417","DOI":"10.3389\/fimmu.2020.599417","article-title":"Treatment of rare inflammatory kidney diseases: Drugs targeting the terminal complement pathway","volume":"11","author":"Dingemanse","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2018.05.018","article-title":"Properdin: A multifaceted molecule involved in inflammation and diseases","volume":"102","author":"Chen","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-5-5","article-title":"Complement anaphylatoxin c5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo","volume":"5","author":"Mukherjee","year":"2008","journal-title":"J. Neuroinflamm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the complement system in the clinical immunology laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin. Lab. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-mbl and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: Intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.4049\/jimmunol.173.11.6921","article-title":"Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex","volume":"173","author":"Bossi","year":"2004","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/eji.200636285","article-title":"Terminal complement complex c5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce th1 polarization","volume":"37","author":"Chen","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"831044","DOI":"10.3389\/fimmu.2021.831044","article-title":"Editorial: Function and dysfunction of complement factor h","volume":"12","author":"Jozsi","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-3083.1994.tb03372.x","article-title":"Formation of the terminal complement complex on agarose beads: Further evidence that vitronectin (complement s-protein) inhibits c9 polymerization","volume":"39","author":"Johnson","year":"1994","journal-title":"Scand. J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.4049\/jimmunol.151.4.2159","article-title":"Clusterin, the human apolipoprotein and complement inhibitor, binds to complement c7, c8 beta, and the b domain of c9","volume":"151","author":"Tschopp","year":"1993","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"918775","DOI":"10.3389\/fimmu.2022.918775","article-title":"Coagulation and complement: Key innate defense participants in a seamless web","volume":"13","author":"Pryzdial","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lenoir, G., D\u2019Ambrosio, J.M., Dieudonne, T., and Copic, A. (2021). Transport pathways that contribute to the cellular distribution of phosphatidylserine. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.737907"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Protty, M.B., Jenkins, P.V., Collins, P.W., and O\u2019Donnell, V.B. (2022). The role of procoagulant phospholipids on the surface of circulating blood cells in thrombosis and haemostasis. Open Biol., 12.","DOI":"10.1098\/rsob.210318"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: As diverse as the granules \u2026 Or not?","volume":"13","author":"Heijnen","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/bi00492a016","article-title":"Proteolytic activation of human factors ix and x by recombinant human factor viia: Effects of calcium, phospholipids, and tissue factor","volume":"29","author":"Komiyama","year":"1990","journal-title":"Biochemistry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2017-08-798520","article-title":"Maestro tissue factor reaches new height","volume":"130","author":"Pryzdial","year":"2017","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17241","DOI":"10.1074\/jbc.M312827200","article-title":"Formation of factors ixa and xa by the extrinsic pathway: Differential regulation by tissue factor pathway inhibitor and antithrombin iii","volume":"279","author":"Lu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood-2017-02-767079","article-title":"Selective factor viii activation by the tissue factor-factor viia-factor xa complex","volume":"130","author":"Kamikubo","year":"2017","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.biochi.2010.05.011","article-title":"Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors","volume":"92","author":"Olson","year":"2010","journal-title":"Biochimie"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/CIRCULATIONAHA.113.003191","article-title":"Factor xa activation of factor v is of paramount importance in initiating the coagulation system: Lessons from a tick salivary protein","volume":"128","author":"Schuijt","year":"2013","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0076-6879(93)22018-B","article-title":"Assembly of prothrombinase complex","volume":"222","author":"Krishnaswamy","year":"1993","journal-title":"Methods Enzymol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/jth.15149","article-title":"Proteolytic activity of contact factor zymogens","volume":"19","author":"Shamanaev","year":"2021","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Mailer, R.K., Rangaswamy, C., Konrath, S., Emsley, J., and Renne, T. (2022). An update on factor xii-driven vascular inflammation. Biochim. Biophys. Acta Mol. Cell Res., 1869.","DOI":"10.1016\/j.bbamcr.2021.119166"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.0608647104","article-title":"Extracellular rna constitutes a natural procoagulant cofactor in blood coagulation","volume":"104","author":"Kannemeier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"Stark","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cell.2009.11.001","article-title":"Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo","volume":"139","author":"Muller","year":"2009","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00281-011-0288-2","article-title":"The procoagulant and proinflammatory plasma contact system","volume":"34","author":"Renne","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.transci.2018.07.003","article-title":"Blood coagulation dissected","volume":"57","author":"Pryzdial","year":"2018","journal-title":"Transfus. Apher. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor xii in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/01.HYP.33.6.1431","article-title":"Bradykinin stimulates tissue plasminogen activator release in human vasculature","volume":"33","author":"Brown","year":"1999","journal-title":"Hypertension"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.molimm.2006.11.012","article-title":"Classical pathway complement activation on human endothelial cells","volume":"44","author":"Yin","year":"2007","journal-title":"Mol. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.imlet.2010.03.012","article-title":"The non-classical functions of the classical complement pathway recognition subcomponent c1q","volume":"131","author":"Nayak","year":"2010","journal-title":"Immunol. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.4049\/jimmunol.0902810","article-title":"Complement component c3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1","volume":"184","author":"Hamad","year":"2010","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.4049\/jimmunol.1300610","article-title":"Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and c3(h2o)","volume":"190","author":"Saggu","year":"2013","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.02-0737com","article-title":"Regulation by complement c3a and c5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells","volume":"17","author":"Monsinjon","year":"2003","journal-title":"FASEB J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e140966","DOI":"10.1172\/JCI140966","article-title":"Endothelial c3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1096\/fj.201902397R","article-title":"In response to complement anaphylatoxin peptides c3a and c5a, human vascular endothelial cells migrate and mediate the activation of b-cells and polarization of t-cells","volume":"34","author":"Shivshankar","year":"2020","journal-title":"FASEB J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI117430","article-title":"C5a-induced expression of p-selectin in endothelial cells","volume":"94","author":"Foreman","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_56","first-page":"168","article-title":"[Effect of c5a on expression of thrombomodulin in endothelial cells in vitro]","volume":"21","author":"Fang","year":"2009","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue Chin. Crit. Care Med. Zhongguo Weizhongbing Jijiuyixue"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1097\/TXD.0000000000000881","article-title":"Complement-mediated damage to the glycocalyx plays a role in renal ischemia-reperfusion injury in mice","volume":"5","author":"Bongoni","year":"2019","journal-title":"Transplant. Direct"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000083842","article-title":"New aspects in thrombotic research: Complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype","volume":"33","author":"Wojta","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2567.2009.03200.x","article-title":"Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot","volume":"129","author":"Gulla","year":"2010","journal-title":"Immunology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.bbapap.2008.03.020","article-title":"The action of mbl-associated serine protease 1 (masp1) on factor xiii and fibrinogen","volume":"1784","author":"Krarup","year":"2008","journal-title":"Biochim. et Biophys. Acta"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1016\/S0021-9258(19)39666-8","article-title":"Complement proteins c5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex","volume":"265","author":"Hamilton","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V68.4.875.875","article-title":"Complement proteins c5b-9 stimulate procoagulant activity through platelet prothrombinase","volume":"68","author":"Wiedmer","year":"1986","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of c5a in the absence of c3: A new complement activation pathway","volume":"12","author":"Sarma","year":"2006","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2012-02-412080","article-title":"Thrombin generates previously unidentified c5 products that support the terminal complement activation pathway","volume":"120","author":"Krisinger","year":"2012","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.147.6.1713","article-title":"The human complement system in thrombin-mediated platelet function","volume":"147","author":"Polley","year":"1978","journal-title":"J. Exp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.150.3.633","article-title":"Human complement in thrombin-mediated platelet function: Uptake of the c5b-9 complex","volume":"150","author":"Polley","year":"1979","journal-title":"J. Exp. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"31877","DOI":"10.1038\/srep31877","article-title":"Masp-3 is the exclusive pro-factor d activator in resting blood: The lectin and the alternative complement pathways are fundamentally linked","volume":"6","author":"Dobo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4049\/jimmunol.1501717","article-title":"Masp-1 and masp-2 do not activate pro-factor d in resting human blood, whereas masp-3 is a potential activator: Kinetic analysis involving specific masp-1 and masp-2 inhibitors","volume":"196","author":"Oroszlan","year":"2016","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V96.8.2784","article-title":"Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase c-dependent pathway protects vascular endothelial cells from complement-mediated injury","volume":"96","author":"Lidington","year":"2000","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"eBioMedicine"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1084\/jem.126.2.189","article-title":"A plasmin-split fragment of c\u20323 as a new chemotactic factor","volume":"126","author":"Ward","year":"1967","journal-title":"J. Exp. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.2020005959","article-title":"Complement inhibition at the level of c3 or c5: Mechanistic reasons for ongoing terminal pathway activity","volume":"137","author":"Mannes","year":"2021","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1084\/jem.157.6.2029","article-title":"Expression of c5a-like biological activities by the fifth component of human complement (c5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments","volume":"157","author":"Wetsel","year":"1983","journal-title":"J. Exp. Med."},{"key":"ref_75","first-page":"587","article-title":"The activation of the alternative pathway c3 convertase by human plasma kallikrein","volume":"45","author":"DiScipio","year":"1982","journal-title":"Immunology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2008.04.027","article-title":"Plasma kallikrein is activated on dermatan sulfate and cleaves factor h","volume":"370","author":"Saito","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0167-4838(82)90307-7","article-title":"Inhibition of human factor xa by various plasma protease inhibitors","volume":"701","author":"Ellis","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0038-1647922","article-title":"The effect of antithrombin iii on the activity of the coagulation factors vii, ix and x","volume":"35","author":"Osterud","year":"1976","journal-title":"Thromb. Haemost."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.molimm.2013.01.009","article-title":"The control of the complement lectin pathway activation revisited: Both c1-inhibitor and antithrombin are likely physiological inhibitors, while alpha2-macroglobulin is not","volume":"54","author":"Parej","year":"2013","journal-title":"Mol. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.126.5.1769","article-title":"Activation of the early components of the classical complement pathway under physiologic conditions","volume":"126","author":"Ziccardi","year":"1981","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"40880","DOI":"10.1074\/jbc.M105934200","article-title":"Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2","volume":"276","author":"Rossi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.molimm.2007.07.008","article-title":"Elucidation of the substrate specificity of the masp-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, c1-inhibitor","volume":"45","author":"Kerr","year":"2008","journal-title":"Mol. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-2776(08)60417-4","article-title":"Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response","volume":"10","author":"Ratnoff","year":"1969","journal-title":"Adv. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.thromres.2010.01.038","article-title":"Alternatively spliced isoforms of tissue factor pathway inhibitor","volume":"125","author":"Maroney","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor: Multiple anticoagulant activities for a single protein","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/eji.201445070","article-title":"Tfpi inhibits lectin pathway of complement activation by direct interaction with masp-2","volume":"45","author":"Keizer","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4049\/jimmunol.2000398","article-title":"Cross-talk between the complement pathway and the contact activation system of coagulation: Activated factor xi neutralizes complement factor h","volume":"206","author":"Puy","year":"2021","journal-title":"J. Immunol."},{"key":"ref_88","first-page":"1536","article-title":"Association of complement factor h polymorphisms with exudative age-related macular degeneration","volume":"12","author":"Chen","year":"2006","journal-title":"Mol. Vis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/jth.14742","article-title":"Contact activation-induced complex formation between complement factor h and coagulation factor xiia","volume":"18","author":"Thangaraj","year":"2020","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Feng, S., Liang, X., Cruz, M.A., Vu, H., Zhou, Z., Pemmaraju, N., Dong, J.F., Kroll, M.H., and Afshar-Kharghan, V. (2013). The interaction between factor h and von willebrand factor. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073715"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/ATVBAHA.113.302280","article-title":"Human complement factor h is a reductase for large soluble von willebrand factor multimers\u2014Brief report","volume":"33","author":"Nolasco","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2013-04-495853","article-title":"The interaction between factor h and vwf increases factor h cofactor activity and regulates vwf prothrombotic status","volume":"123","author":"Rayes","year":"2014","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0034-1383547","article-title":"Thrombotic microangiopathies and the linkage between von willebrand factor and the alternative complement pathway","volume":"40","author":"Turner","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2014-06-585430","article-title":"Von willebrand factor is a cofactor in complement regulation","volume":"125","author":"Feng","year":"2015","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"14477","DOI":"10.1074\/jbc.270.24.14477","article-title":"Purification and characterization of tafi, a thrombin-activable fibrinolysis inhibitor","volume":"270","author":"Bajzar","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1348-0421.2002.tb02669.x","article-title":"Inactivation of c3a and c5a octapeptides by carboxypeptidase r and carboxypeptidase n","volume":"46","author":"Campbell","year":"2002","journal-title":"Microbiol. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2016.07.017","article-title":"Thrombomodulin enhances complement regulation through strong affinity interactions with factor h and c3b-factor h complex","volume":"145","author":"Heurich","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5582\/bst.2016.01052","article-title":"Dual modulating functions of thrombomodulin in the alternative complement pathway","volume":"10","author":"Tateishi","year":"2016","journal-title":"Biosci. Trends"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/fpd.2013.1704","article-title":"Global incidence of human shiga toxin-producing Escherichia coli infections and deaths: A systematic review and knowledge synthesis","volume":"11","author":"Majowicz","year":"2014","journal-title":"Foodborne Pathog. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Rivas, M., Chinen, I., Miliwebsky, E., and Masana, M. (2014). Risk factors for shiga toxin-producing escherichia coli-associated human diseases. Microbiol. Spectr.","DOI":"10.1128\/microbiolspec.EHEC-0002-2013"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/joim.12546","article-title":"Haemolytic uraemic syndrome","volume":"281","author":"Karpman","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1152\/ajprenal.00376.2017","article-title":"Advances in our understanding of the pathogenesis of hemolytic uremic syndromes","volume":"314","author":"Bowen","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cis196","article-title":"Need for long-term follow-up in enterohemorrhagic escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae","volume":"54","author":"Rosales","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1462-5822.2007.01103.x","article-title":"Attaching effacing escherichia coli and paradigms of tir-triggered actin polymerization: Getting off the pedestal","volume":"10","author":"Frankel","year":"2008","journal-title":"Cell Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/infdis\/jiv013","article-title":"The serine protease pic from enteroaggregative escherichia coli mediates immune evasion by the direct cleavage of complement proteins","volume":"212","author":"Abreu","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Ayala-Lujan, J.L., Vijayakumar, V., Gong, M., Smith, R., Santiago, A.E., and Ruiz-Perez, F. (2014). Broad spectrum activity of a lectin-like bacterial serine protease family on human leukocytes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107920"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1128\/IAI.00488-10","article-title":"Espp, a serine protease of enterohemorrhagic escherichia coli, impairs complement activation by cleaving complement factors c3\/c3b and c5","volume":"78","author":"Orth","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Weiss, A., Joerss, H., and Brockmeyer, J. (2014). Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial spate protease esppalpha from enterohemorrhagic E. coli. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111363"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1365-2958.1997.5141874.x","article-title":"Characterization of an exported protease from shiga toxin-producing escherichia coli","volume":"25","author":"Djafari","year":"1997","journal-title":"Mol. Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1084\/jem.20030255","article-title":"Potentiation of c1 esterase inhibitor by stce, a metalloprotease secreted by escherichia coli o157:H7","volume":"199","author":"Lathem","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.str.2012.02.015","article-title":"Structural insight into the bacterial mucinase stce essential to adhesion and immune evasion during enterohemorrhagic E. coli infection","volume":"20","author":"Yu","year":"2012","journal-title":"Structure"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"12980","DOI":"10.1074\/jbc.270.22.12980","article-title":"Inorganic polyphosphates in the acquisition of competence in Escherichia coli","volume":"270","author":"Castuma","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood-2013-07-515726","article-title":"Polyphosphate suppresses complement via the terminal pathway","volume":"123","author":"Wat","year":"2014","journal-title":"Blood"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.thromres.2009.11.028","article-title":"Factor xii: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis","volume":"125","author":"Stavrou","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor xii provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor xii","volume":"202","author":"Renne","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_120","first-page":"1073","article-title":"Shiga-toxin-producing escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1755.2002.00502.x","article-title":"Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model","volume":"62","author":"Rutjes","year":"2002","journal-title":"Kidney Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/JCM.00860-12","article-title":"Multicenter evaluation of a sequence-based protocol for subtyping shiga toxins and standardizing stx nomenclature","volume":"50","author":"Scheutz","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Gallegos, K.M., Conrady, D.G., Karve, S.S., Gunasekera, T.S., Herr, A.B., and Weiss, A.A. (2012). Shiga toxin binding to glycolipids and glycans. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030368"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1159\/000088523","article-title":"Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome","volume":"25","author":"Clayton","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/iai.60.4.1536-1543.1992","article-title":"Shiga toxin-associated hemolytic uremic syndrome: Combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro","volume":"60","author":"Louise","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00467-003-1395-7","article-title":"Hemolytic uremic syndrome induced by lipopolysaccharide and shiga-like toxin","volume":"19","author":"Ikeda","year":"2004","journal-title":"Pediatr. Nephrol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2006050419","article-title":"A murine model of hus: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease","volume":"17","author":"Keepers","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4049\/jimmunol.181.2.1460","article-title":"Fractalkine and cx3cr1 mediate leukocyte capture by endothelium in response to shiga toxin","volume":"181","author":"Zanchi","year":"2008","journal-title":"J. Immunol."},{"key":"ref_129","first-page":"65","article-title":"Shiga toxin: Biochemistry, genetics, mode of action, and role in pathogenesis","volume":"180","author":"Tesh","year":"1992","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0966-842X(96)10017-2","article-title":"Role of verotoxin receptors in pathogenesis","volume":"4","author":"Lingwood","year":"1996","journal-title":"Trends Microbiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/358510a0","article-title":"Retrograde transport of endocytosed shiga toxin to the endoplasmic reticulum","volume":"358","author":"Sandvig","year":"1992","journal-title":"Nature"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1432-1033.1988.tb13756.x","article-title":"Site of action of a vero toxin (vt2) from escherichia coli o157:H7 and of shiga toxin on eukaryotic ribosomes. Rna n-glycosidase activity of the toxins","volume":"171","author":"Endo","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Lee, M.S., Koo, S., Jeong, D.G., and Tesh, V.L. (2016). Shiga toxins as multi-functional proteins: Induction of host cellular stress responses, role in pathogenesis and therapeutic applications. Toxins, 8.","DOI":"10.3390\/toxins8030077"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4161\/viru.26143","article-title":"New insights into shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome","volume":"4","author":"Marsden","year":"2013","journal-title":"Virulence"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1462-5822.2011.01684.x","article-title":"Activation of cell stress response pathways by shiga toxins","volume":"14","author":"Tesh","year":"2012","journal-title":"Cell Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","article-title":"Shiga toxin-associated hemolytic uremic syndrome: Pathophysiology of endothelial dysfunction","volume":"25","author":"Zoja","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/INF.0b013e3182074d22","article-title":"Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome","volume":"30","author":"Brigotti","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"He, X., Ardissino, G., Patfield, S., Cheng, L.W., Silva, C.J., and Brigotti, M. (2018). An improved method for the sensitive detection of shiga toxin 2 in human serum. Toxins, 10.","DOI":"10.3390\/toxins10020059"},{"key":"ref_139","first-page":"105","article-title":"Shiga toxin pathogenesis: Kidney complications and renal failure","volume":"357","author":"Obrig","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1300122","article-title":"Identification of tlr4 as the receptor that recognizes shiga toxins in human neutrophils","volume":"191","author":"Brigotti","year":"2013","journal-title":"J. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Stahl, A.L., Arvidsson, I., Johansson, K.E., Chromek, M., Rebetz, J., Loos, S., Kristoffersson, A.C., Bekassy, Z.D., Morgelin, M., and Karpman, D. (2015). A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004619"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Villysson, A., Tontanahal, A., and Karpman, D. (2017). Microvesicle involvement in shiga toxin-associated infection. Toxins, 9.","DOI":"10.3390\/toxins9110376"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood-2002-10-3301","article-title":"Molecular and functional analysis of shiga toxin-induced response patterns in human vascular endothelial cells","volume":"102","author":"Matussek","year":"2003","journal-title":"Blood"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood.V86.12.4553.bloodjournal86124553","article-title":"Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions","volume":"86","author":"Morigi","year":"1995","journal-title":"Blood"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2002.00503.x","article-title":"Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via nf-kappab dependent up-regulation of il-8 and mcp-1","volume":"62","author":"Zoja","year":"2002","journal-title":"Kidney Int."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1182\/blood.V98.6.1828","article-title":"Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress","volume":"98","author":"Morigi","year":"2001","journal-title":"Blood"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"33118","DOI":"10.1074\/jbc.M113.487413","article-title":"Interaction of shiga toxin with the a-domains and multimers of von willebrand factor","volume":"288","author":"Lo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/IAI.01591-14","article-title":"Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid p component","volume":"82","author":"Dettmar","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00467-002-1025-9","article-title":"Shigatoxin-1 binding and receptor expression in human kidneys do not change with age","volume":"18","author":"Ergonul","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1046\/j.1523-1755.2000.00095.x","article-title":"Cytotoxic effect of shiga toxin-1 on human glomerular epithelial cells","volume":"57","author":"Hughes","year":"2000","journal-title":"Kidney Int."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2353\/ajpath.2006.051331","article-title":"Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling","volume":"169","author":"Morigi","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000045953","article-title":"Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells","volume":"88","author":"Hughes","year":"2001","journal-title":"Nephron"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00467-013-2561-1","article-title":"Current evidence for the role of complement in the pathogenesis of shiga toxin haemolytic uraemic syndrome","volume":"29","author":"Keir","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-0034-1375295","article-title":"Role of complement in enterohemorrhagic escherichia coli-induced hemolytic uremic syndrome","volume":"40","author":"Wurzner","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00467-017-3850-x","article-title":"Shiga toxin triggers endothelial and podocyte injury: The role of complement activation","volume":"34","author":"Zoja","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_157","first-page":"126","article-title":"Renal histopathology in the hemolytic-uremic syndrome following shigellosis","volume":"21","author":"Koster","year":"1984","journal-title":"Clin. Nephrol."},{"key":"ref_158","first-page":"168","article-title":"The complement system in hemolytic-uremic syndrome in childhood","volume":"13","author":"Monnens","year":"1980","journal-title":"Clin. Nephrol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","article-title":"Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome","volume":"62","author":"Robson","year":"1992","journal-title":"Nephron"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic escherichia coli-induced hemolytic uremic syndrome","volume":"117","author":"Stahl","year":"2011","journal-title":"Blood"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cei.12601","article-title":"Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome","volume":"181","author":"Ferraris","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.1502377","article-title":"Early terminal complement blockade and c6 deficiency are protective in enterohemorrhagic escherichia coli-infected mice","volume":"197","author":"Arvidsson","year":"2016","journal-title":"J. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor h: Evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J. Immunol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molimm.2013.11.009","article-title":"Interaction of shiga toxin 2 with complement regulators of the factor h protein family","volume":"58","author":"Poolpol","year":"2014","journal-title":"Mol. Immunol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.01079-12","article-title":"Shiga toxin 2 reduces complement inhibitor cd59 expression on human renal tubular epithelial and glomerular endothelial cells","volume":"81","author":"Ehrlenbach","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.4049\/jimmunol.1100280","article-title":"The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway","volume":"187","author":"Iwaki","year":"2011","journal-title":"J. Immunol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.kint.2016.05.011","article-title":"Human mannose-binding lectin inhibitor prevents shiga toxin-induced renal injury","volume":"90","author":"Ozaki","year":"2016","journal-title":"Kidney Int."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000363299","article-title":"The effect of shiga toxin on weibel-palade bodies in primary human endothelial cells","volume":"4","author":"Geelen","year":"2014","journal-title":"Nephron Extra"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by shiga toxin promotes exuberant c3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20041497","article-title":"Platelet activation leads to activation and propagation of the complement system","volume":"201","author":"Cruz","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1182\/blood-2005-05-2111","article-title":"Hemolytic uremic syndrome-associated shiga toxins promote endothelial-cell secretion and impair adamts13 cleavage of unusually large von willebrand factor multimers","volume":"106","author":"Nolasco","year":"2005","journal-title":"Blood"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.thromres.2013.03.006","article-title":"Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium","volume":"131","author":"Grabowski","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.4049\/jimmunol.1402470","article-title":"Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome","volume":"194","author":"Arvidsson","year":"2015","journal-title":"J. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"18205","DOI":"10.1016\/S0021-9258(19)81346-7","article-title":"Complement proteins c5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor va and express prothrombinase activity","volume":"263","author":"Sims","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Stahl, A.L., Sartz, L., Nelsson, A., Bekassy, Z.D., and Karpman, D. (2009). Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006990"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1681\/ASN.2013050450","article-title":"Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement","volume":"25","author":"Locatelli","year":"2014","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Qu, L., and Jiao, B. (2023). The interplay between immune and metabolic pathways in kidney disease. Cells, 12.","DOI":"10.3390\/cells12121584"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41423-022-00840-x","article-title":"Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology","volume":"19","author":"Chi","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Ding, S., Xu, S., Ma, Y., Liu, G., Jang, H., and Fang, J. (2019). Modulatory mechanisms of the nlrp3 inflammasomes in diabetes. Biomolecules, 9.","DOI":"10.3390\/biom9120850"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ped.14053","article-title":"Pathogenic functions and diagnostic utility of cytokines\/chemokines in ehec-hus","volume":"62","author":"Shimizu","year":"2020","journal-title":"Pediatr. Int."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1081\/JDI-120013959","article-title":"Cytokine expression in the renal tubular epithelial cells stimulated by shiga toxin 2 of escherichia coli o157:H7","volume":"24","author":"Lee","year":"2002","journal-title":"Ren. Fail."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"619096","DOI":"10.3389\/fimmu.2020.619096","article-title":"Activation of the nlrp3 inflammasome contributes to shiga toxin-induced hemolytic uremic syndrome in a mouse model","volume":"11","author":"Song","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1182\/blood-2013-05-502229","article-title":"C3a modulates il-1beta secretion in human monocytes by regulating atp efflux and subsequent nlrp3 inflammasome activation","volume":"122","author":"Asgari","year":"2013","journal-title":"Blood"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1300489","article-title":"Cutting edge: The nlrp3 inflammasome links complement-mediated inflammation and il-1beta release","volume":"191","author":"Laudisi","year":"2013","journal-title":"J. Immunol."},{"key":"ref_186","first-page":"2903","article-title":"The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to nlrp3 inflammasome activation","volume":"126","author":"Triantafilou","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.trstmh.2012.04.001","article-title":"Haemolytic uraemic syndrome during shigellosis","volume":"106","author":"Butler","year":"2012","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3201\/eid0104.950407","article-title":"An outbreak of hemolytic uremic syndrome associated with antibiotic treatment of hospital inpatients for dysentery","volume":"1","author":"Fontaine","year":"1995","journal-title":"Emerg. Infect. Dis."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3201\/eid0104.950406","article-title":"Does treatment of bloody diarrhea due to Shigella dysenteriae type 1 with ampicillin precipitate hemolytic uremic syndrome?","volume":"1","year":"1995","journal-title":"Emerg. Infect. Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0140-6736(94)92815-0","article-title":"Haemolytic-uraemic syndrome in adults with resistant Shigella dysenteriae type i","volume":"344","author":"Bloom","year":"1994","journal-title":"Lancet"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/383474","article-title":"A pediatric cluster of Shigella dysenteriae serotype 1 diarrhea with hemolytic uremic syndrome in 2 families from france","volume":"38","author":"Houdouin","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s004670100049","article-title":"Post-dysenteric hemolytic uremic syndrome in bulawayo, zimbabwe","volume":"16","author":"Oneko","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(89)90662-4","article-title":"Shigella dysenteriae type 1 infections in us travellers to mexico, 1988","volume":"2","author":"Parsonnet","year":"1989","journal-title":"Lancet"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/tropej\/41.5.281","article-title":"Epidemic Shigella dysenteriae type 1 in natal","volume":"41","author":"Rollins","year":"1995","journal-title":"J. Trop. Pediatr."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1086\/499236","article-title":"Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in bangladesh","volume":"42","author":"Bennish","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/CMR.17.4.926-941.2004","article-title":"Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome","volume":"17","author":"Tzipori","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJM197804272981702","article-title":"Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes","volume":"298","author":"Koster","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_198","first-page":"7","article-title":"An animal model of haemolytic--uraemic syndrome in shigellosis: Lipopolysaccharides of Shigella dysenteriae i and S. flexneri produce leucocyte-mediated renal cortical necrosis in rabbits","volume":"66","author":"Butler","year":"1985","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.micpath.2011.02.010","article-title":"Exposure of thomsen-friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase a","volume":"50","author":"Coats","year":"2011","journal-title":"Microb. Pathog."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0340-904X(78)80054-2","article-title":"The thomsen agglutination phenomenon: A discovery revisited 50 years later","volume":"154","author":"Vaith","year":"1978","journal-title":"Z. Immunitatsforschung. Immunobiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00467-007-0518-y","article-title":"Streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"23","author":"Copelovitch","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.inf.0000223494.83542.ad","article-title":"T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia","volume":"25","author":"Huang","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"641656","DOI":"10.3389\/fimmu.2021.641656","article-title":"Complement genetic variants and fh desialylation in s. Pneumoniae-haemolytic uraemic syndrome","volume":"12","author":"Corvillo","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_204","first-page":"15","article-title":"Neuraminidase induced hemolytic anemia. Experimental and clinical observations (author\u2019s transl)","volume":"124","author":"Poschmann","year":"1976","journal-title":"Monatsschrift Kinderheilkd."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jcp.38.4.438","article-title":"Verotoxin and neuraminidase induced platelet aggregating activity in plasma: Their possible role in the pathogenesis of the haemolytic uraemic syndrome","volume":"38","author":"Rose","year":"1985","journal-title":"J. Clin. Pathol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.mehy.2013.05.030","article-title":"Does dysregulated complement activation contribute to haemolytic uraemic syndrome secondary to streptococcus pneumoniae?","volume":"81","author":"Gilbert","year":"2013","journal-title":"Med. Hypotheses"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.imbio.2011.07.022","article-title":"Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?","volume":"217","author":"Johnson","year":"2012","journal-title":"Immunobiology"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V61.6.1196.1196","article-title":"The role of sialic acid in the dysfibrinogenemia associated with liver disease: Distribution of sialic acid on the constituent chains","volume":"61","author":"Martinez","year":"1983","journal-title":"Blood"},{"key":"ref_209","first-page":"367","article-title":"Functional and metabolic properties of human asialofibrinogen","volume":"89","author":"Martinez","year":"1977","journal-title":"J. Lab. Clin. Med."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jth.15528","article-title":"Desialylation of o-glycans activates von willebrand factor by destabilizing its autoinhibitory module","volume":"20","author":"Voos","year":"2022","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"e12530","DOI":"10.1002\/rth2.12530","article-title":"In vitro characterization of ct-001-a short-acting factor viia with enhanced prohemostatic activity","volume":"5","author":"Sim","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/S0021-9258(17)43103-6","article-title":"Blood clotting factor ix. Loss of activity after cleavage of sialic acid residues","volume":"259","author":"Chavin","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/0304-4165(76)90301-9","article-title":"On the significance of the carbohydrate moieties of bovine prothrombin for clotting activity","volume":"421","author":"Henriksen","year":"1976","journal-title":"Biochim. et Biophys. Acta"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0006-291X(71)90069-6","article-title":"Properties of asialo and aglycoprothrombin","volume":"45","author":"Nelsestuen","year":"1971","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0009-8981(59)90076-2","article-title":"Immunochemical experiments with prothrombin and thrombin","volume":"4","author":"Schwick","year":"1959","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_216","first-page":"219","article-title":"Hemolytic-uremic syndrome in pneumococcal meningitis and infection. Importance of t-transformation","volume":"141","author":"Eber","year":"1993","journal-title":"Monatsschrift Kinderheilkd. Organ. Dtsch. Ges. Kinderheilkd."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/INF.0b013e31829ee872","article-title":"Diagnosis of streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"32","author":"Loupiac","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.1501388","article-title":"Complement evasion mediated by enhancement of captured factor h: Implications for protection of self-surfaces from complement","volume":"195","author":"Herbert","year":"2015","journal-title":"J. Immunol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.4049\/jimmunol.181.10.7138","article-title":"Species-specific interaction of Streptococcus pneumoniae with human complement factor h","volume":"181","author":"Lu","year":"2008","journal-title":"J. Immunol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000185598","article-title":"Hemorrhagic colitis with streptococcus pyogenes preceding hemolytic uremic syndrome during early pregnancy","volume":"52","author":"Bollaert","year":"1989","journal-title":"Nephron"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1053\/j.ajkd.2005.06.010","article-title":"An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome","volume":"46","author":"Izumi","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Yildiz, B., Kural, N., and Yarar, C. (2004). Atypical hemolytic uremic syndrome associated with group a beta hemolytic streptococcus. Pediatr. Nephrol., 19.","DOI":"10.1007\/s00467-004-1536-7"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00467-003-1191-4","article-title":"Hemolytic uremic syndrome associated with group a beta-hemolytic streptococcus","volume":"18","author":"Shepherd","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1128\/IAI.70.11.6206-6214.2002","article-title":"Acquisition of regulators of complement activation by streptococcus pyogenes serotype m1","volume":"70","author":"Pandiripally","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1128\/IAI.71.12.7119-7128.2003","article-title":"Recruitment of complement factor h-like protein 1 promotes intracellular invasion by group a streptococci","volume":"71","author":"Pandiripally","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4049\/jimmunol.154.1.375","article-title":"Ig-binding surface proteins of streptococcus pyogenes also bind human c4b-binding protein (c4bp), a regulatory component of the complement system","volume":"154","author":"Thern","year":"1995","journal-title":"J. Immunol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1538-7836.2003.00105.x","article-title":"Interactions between surface proteins of streptococcus pyogenes and coagulation factors modulate clotting of human plasma","volume":"1","author":"Herwald","year":"2003","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Inoue, D., Oda, T., Iwama, S., Hoshino, T., Mukae, M., Sakai, T., Kojima, A., Uchida, T., Kojima, T., and Sugisaki, K. (2022). Thrombotic microangiopathy with transiently positive direct coombs test in an adult with poststreptococcal acute glomerulonephritis: A case report. BMC Nephrol., 23.","DOI":"10.1186\/s12882-022-02684-z"},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Oda, T., Yoshizawa, N., Yamakami, K., Sakurai, Y., Takechi, H., Yamamoto, K., Oshima, N., and Kumagai, H. (2012). The role of nephritis-associated plasmin receptor (naplr) in glomerulonephritis associated with streptococcal infection. J. Biomed. Biotechnol., 2012.","DOI":"10.1155\/2012\/417675"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(79)91343-6","article-title":"Exchange transfusion with heparinised fresh blood in necrotising enterocolitis","volume":"1","author":"Poschmann","year":"1979","journal-title":"Lancet"},{"key":"ref_231","first-page":"121","article-title":"Necrotising enterocolitis and neuraminidase-producing bacteria","volume":"35","author":"Seger","year":"1980","journal-title":"Helv. Paediatr. Acta"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0022-3468(81)80844-5","article-title":"Pediatric surgical patients with severe anaerobic infection: Report of 16 t-antigen positive cases and possible hazards of blood transfusion","volume":"16","author":"Seges","year":"1981","journal-title":"J. Pediatr. Surg."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/A:1018565316310","article-title":"Monoclonal antibodies for the detection of desialylation of erythrocyte membranes during haemolytic disease and haemolytic uraemic syndrome caused by the in vivo action of microbial neuraminidase","volume":"14","author":"Seitz","year":"1997","journal-title":"Glycoconj. J."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/589753","article-title":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants","volume":"47","author":"Paddock","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00467-001-0798-6","article-title":"Hemolytic uremic syndrome due to an altered factor h triggered by neonatal pertussis","volume":"17","author":"Berner","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00467-010-1449-6","article-title":"Hemolytic uremic syndrome caused by Bordetella pertussis infection","volume":"25","author":"Chaturvedi","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10096-006-0171-6","article-title":"Hemolytic uremic syndrome in an infant following Bordetella pertussis infection","volume":"25","author":"Pela","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Saida, K., Ogura, M., Kano, Y., Ishimori, S., Yoshikawa, T., Nagata, H., Sato, M., Kamei, K., and Ishikura, K. (2018). Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection\u2014Is plasma exchange or eculizumab use necessary?. BMC Nephrol., 19.","DOI":"10.1186\/s12882-018-1168-y"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00109-015-1259-1","article-title":"Complement evasion by Bordetella pertussis: Implications for improving current vaccines","volume":"93","author":"Jongerius","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/IAI.69.5.3067-3072.2001","article-title":"Brka protein of Bordetella pertussis inhibits the classical pathway of complement after c1 deposition","volume":"69","author":"Barnes","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Marr, N., Shah, N.R., Lee, R., Kim, E.J., and Fernandez, R.C. (2011). Bordetella pertussis autotransporter vag8 binds human c1 esterase inhibitor and confers serum resistance. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020585"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1508.081511","article-title":"Bordetella pertussis strains with increased toxin production associated with pertussis resurgence","volume":"15","author":"Mooi","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"e02823-20","DOI":"10.1128\/mBio.02823-20","article-title":"Molecular basis for Bordetella pertussis interference with complement, coagulation, fibrinolytic, and contact activation systems: The cryo-em structure of the vag8-c1 inhibitor complex","volume":"12","author":"Dhillon","year":"2021","journal-title":"mBio"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/iai.65.9.3638-3643.1997","article-title":"Bordetella pertussis binds the human complement regulator c4bp: Role of filamentous hemagglutinin","volume":"65","author":"Berggard","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO;2-0","article-title":"Bordetella pertussis binds to human c4b-binding protein (c4bp) at a site similar to that used by the natural ligand c4b","volume":"31","author":"Berggard","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1574-6968.1998.tb13026.x","article-title":"Serum resistance in bvg-regulated mutants of Bordetella pertussis","volume":"163","author":"Fernandez","year":"1998","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molimm.2013.05.222","article-title":"Human complement control and complement evasion by pathogenic microbes--tipping the balance","volume":"56","author":"Zipfel","year":"2013","journal-title":"Mol. Immunol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.molimm.2010.11.015","article-title":"Interactions between Bordetella pertussis and the complement inhibitor factor h","volume":"48","author":"Amdahl","year":"2011","journal-title":"Mol. Immunol."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Meri, T., Amdahl, H., Lehtinen, M.J., Hyvarinen, S., McDowell, J.V., Bhattacharjee, A., Meri, S., Marconi, R., Goldman, A., and Jokiranta, T.S. (2013). Microbes bind complement inhibitor factor h via a common site. PLoS Pathog., 9.","DOI":"10.1371\/annotation\/41169409-3260-4295-baf4-a1a4621a8e48"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/ajkd.2003.50135","article-title":"Hemolytic uremic syndrome in association with typhoid fever","volume":"41","author":"Albaqali","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.132.1.376","article-title":"Complement activation via the alternative pathway by purified salmonella lipopolysaccharide is affected by its structure but not its o-antigen length","volume":"132","author":"Grossman","year":"1984","journal-title":"J. Immunol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0161-5890(90)90152-P","article-title":"Salmonella o antigen-specific oligosaccharide-octyl conjugates activate complement via the alternative pathway at different rates depending on the structure of the o antigen","volume":"27","author":"Grossman","year":"1990","journal-title":"Mol. Immunol."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Hart, P.J., O\u2019Shaughnessy, C.M., Siggins, M.K., Bobat, S., Kingsley, R.A., Goulding, D.A., Crump, J.A., Reyburn, H., Micoli, F., and Dougan, G. (2016). Differential killing of Salmonella enterica serovar typhi by antibodies targeting vi and lipopolysaccharide o:9 antigen. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0145945"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/150.3.436","article-title":"Reexamination of the protective role of the capsular polysaccharide (vi antigen) of Salmonella typhi","volume":"150","author":"Robbins","year":"1984","journal-title":"J. Infect. Dis."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1462-5822.2004.00483.x","article-title":"Antiprotease inactivation by Salmonella enterica released from infected macrophages","volume":"7","author":"Lahteenmaki","year":"2005","journal-title":"Cell. Microbiol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.febslet.2007.03.049","article-title":"The surface protease pgte of Salmonella enterica affects complement activity by proteolytically cleaving c3b, c4b and c5","volume":"581","author":"Ramu","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Riva, R., Korhonen, T.K., and Meri, S. (2015). The outer membrane protease pgte of Salmonella enterica interferes with the alternative complement pathway by cleaving factors b and h. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00063"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1128\/JB.00458-10","article-title":"The omptins of yersinia pestis and Salmonella enterica cleave the reactive center loop of plasminogen activator inhibitor 1","volume":"192","author":"Haiko","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/j.1538-7836.2010.04014.x","article-title":"Thrombin-activatable fibrinolysis inhibitor is degraded by Salmonella enterica and yersinia pestis","volume":"8","author":"Haiko","year":"2010","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jinf.2018.03.008","article-title":"Activation of coagulation and endothelium with concurrent impairment of anticoagulant mechanisms in patients with typhoid fever","volume":"77","author":"Parry","year":"2018","journal-title":"J. Infect."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(99)00961-7","article-title":"Isolation of shigella sonnei lysogenic for a bacteriophage encoding gene for production of shiga toxin","volume":"353","author":"Beutin","year":"1999","journal-title":"Lancet"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3201\/eid2204.151825","article-title":"Shiga toxin 1-producing shigella sonnei infections, california, united states, 2014\u20132015","volume":"22","author":"Lamba","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3201\/eid2105.140621","article-title":"Characterization of shigella sonnei isolate carrying shiga toxin 2-producing gene","volume":"21","author":"Nyholm","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0923-2508(01)01249-9","article-title":"Shiga-toxin-converting bacteriophages","volume":"152","author":"Schmidt","year":"2001","journal-title":"Res. Microbiol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AEM.01158-13","article-title":"Shiga toxin 2-encoding bacteriophages in human fecal samples from healthy individuals","volume":"79","author":"Quiros","year":"2013","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1128\/AEM.64.7.2443-2448.1998","article-title":"Abundance in sewage of bacteriophages that infect escherichia coli o157:H7 and that carry the shiga toxin 2 gene","volume":"64","author":"Muniesa","year":"1998","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1128\/AEM.65.12.5615-5618.1999","article-title":"Comparative survival of free shiga toxin 2-encoding phages and escherichia coli strains outside the gut","volume":"65","author":"Muniesa","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00253-015-7236-3","article-title":"Shiga toxins: From structure and mechanism to applications","volume":"100","author":"Chan","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.idcr.2017.02.003","article-title":"Shigella sonnei and hemolytic uremic syndrome: A case report and literature review","volume":"8","author":"Adams","year":"2017","journal-title":"IDCases"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Armstrong, S.M., Wang, C., Tigdi, J., Si, X., Dumpit, C., Charles, S., Gamage, A., Moraes, T.J., and Lee, W.L. (2012). Influenza infects lung microvascular endothelium leading to microvascular leak: Role of apoptosis and claudin-5. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047323"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","article-title":"Influenza virus","volume":"26","author":"Hutchinson","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00467-010-1690-z","article-title":"Pandemic h1n1 influenza a infection and (atypical) hus--more than just another trigger?","volume":"26","author":"Allen","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/0886022X.2010.486491","article-title":"Triggering of atypical hemolytic uremic syndrome by influenza a (h1n1)","volume":"32","author":"Bento","year":"2010","journal-title":"Ren. Fail."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00467-010-1649-0","article-title":"Hemolytic uremic syndrome triggered with a new pandemic virus: Influenza a (h1n1)","volume":"26","author":"Caltik","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-010-1636-5","article-title":"Atypical hemolytic uremic syndrome associated with h1n1 influenza a virus infection","volume":"26","author":"Trachtman","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000046102","article-title":"Hemolytic uremic syndrome associated with influenza a virus infection","volume":"89","author":"Watanabe","year":"2001","journal-title":"Nephron"},{"key":"ref_277","doi-asserted-by":"crossref","unstructured":"Kobbe, R., Schild, R., Christner, M., Oh, J., Loos, S., and Kemper, M.J. (2017). Case report\u2014Atypical hemolytic uremic syndrome triggered by influenza b. BMC Nephrol., 18.","DOI":"10.1186\/s12882-017-0512-y"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/MPH.0000000000001180","article-title":"Steroid responsive atypical hemolytic uremic syndrome triggered by influenza b infection","volume":"41","author":"Mittal","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00431-017-2856-5","article-title":"Occurrence of atypical hus associated with influenza b","volume":"176","author":"Vandermeulen","year":"2017","journal-title":"Eur. J. Pediatr."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2013-07-515536","article-title":"Influenza virus h1n1 activates platelets through fcgammariia signaling and thrombin generation","volume":"123","author":"Boilard","year":"2014","journal-title":"Blood"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1378\/chest.11-2860","article-title":"In vivo platelet activation in critically ill patients with primary 2009 influenza a(h1n1)","volume":"141","author":"Rondina","year":"2012","journal-title":"Chest"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4049\/jimmunol.128.2.629","article-title":"Guinea pig erythrocytes, after their contact with influenza virus, acquire the ability to activate the human alternative complement pathway through virus-induced desialation of the cells","volume":"128","author":"Lambre","year":"1982","journal-title":"J. Immunol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jinf.2011.07.004","article-title":"Excessive innate immune response and mutant d222g\/n in severe a (h1n1) pandemic influenza","volume":"63","author":"Berdal","year":"2011","journal-title":"J. Infect."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1165\/rcmb.2012-0428OC","article-title":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza h5n1 virus infection","volume":"49","author":"Sun","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","article-title":"Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and c3 glomerulopathy: Core curriculum 2015","volume":"66","author":"Noris","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","article-title":"Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations","volume":"2","author":"Salvadori","year":"2013","journal-title":"World J. Nephrol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.ajkd.2014.06.035","article-title":"Complement in kidney disease: Core curriculum 2015","volume":"65","author":"Thurman","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-017-3783-4","article-title":"Influenza-associated thrombotic microangiopathies","volume":"33","author":"Bitzan","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5414\/CNCS110219","article-title":"Influenza-associated hemolytic uremic syndrome: The pathogenic role of the virus","volume":"9","author":"Silecchia","year":"2021","journal-title":"Clin. Nephrol. Case Stud."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-101-5-716_2","article-title":"A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome","volume":"101","author":"Boccia","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"e9358","DOI":"10.1097\/MD.0000000000009358","article-title":"Efficacy of eculizumab in an adult patient with hiv-associated hemolytic uremic syndrome: A case report","volume":"96","author":"Freist","year":"2017","journal-title":"Medicine"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ckj\/sfw035","article-title":"Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab","volume":"9","author":"Jin","year":"2016","journal-title":"Clin. Kidney J."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/infdis\/jiv074","article-title":"Hiv coinfection enhances complement activation during sepsis","volume":"212","author":"Huson","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Huber, M., Fischer, M., Misselwitz, B., Manrique, A., Kuster, H., Niederost, B., Weber, R., von Wyl, V., Gunthard, H.F., and Trkola, A. (2006). Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of hiv-1 infection. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030441"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/162.6.1227","article-title":"Activation of the complement system in human immunodeficiency virus infection: Relevance of the classical pathway to pathogenesis and disease severity","volume":"162","author":"Senaldi","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1128\/jvi.67.1.53-59.1993","article-title":"Complement activation by human monoclonal antibodies to human immunodeficiency virus","volume":"67","author":"Spear","year":"1993","journal-title":"J. Virol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1600-065X.2001.1800115.x","article-title":"The supportive role of complement in hiv pathogenesis","volume":"180","author":"Stoiber","year":"2001","journal-title":"Immunol. Rev."},{"key":"ref_298","first-page":"51","article-title":"The role of neutralizing antibodies in hiv infection","volume":"8","author":"Humbert","year":"2006","journal-title":"AIDS Rev."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molimm.2004.06.015","article-title":"Mannose binding lectin (mbl) and hiv","volume":"42","author":"Ji","year":"2005","journal-title":"Mol. Immunol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1084\/jem.169.1.185","article-title":"A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus","volume":"169","author":"Ezekowitz","year":"1989","journal-title":"J. Exp. Med."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00002030-199310000-00002","article-title":"Complement activation upon binding of mannan-binding protein to hiv envelope glycoproteins","volume":"7","author":"Haurum","year":"1993","journal-title":"Aids"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1099\/0022-1317-81-4-949","article-title":"Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1","volume":"81","author":"Saifuddin","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1099\/vir.0.18734-0","article-title":"Glycosylation inhibitors and neuraminidase enhance human immunodeficiency virus type 1 binding and neutralization by mannose-binding lectin","volume":"84","author":"Hart","year":"2003","journal-title":"J. Gen. Virol."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/088922204322996563","article-title":"Interaction of mannose-binding lectin with hiv type 1 is sufficient for virus opsonization but not neutralization","volume":"20","author":"Ying","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.4049\/jimmunol.173.8.4775","article-title":"Cutting edge: Productive hiv-1 infection of dendritic cells via complement receptor type 3 (cr3, cd11b\/cd18)","volume":"173","author":"Bajtay","year":"2004","journal-title":"J. Immunol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/eji.200425940","article-title":"C-type lectin-independent interaction of complement opsonized hiv with monocyte-derived dendritic cells","volume":"35","author":"Pruenster","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00002030-199708000-00002","article-title":"Two parallel routes of the complement-mediated antibody-dependent enhancement of hiv-1 infection","volume":"11","author":"Prohaszka","year":"1997","journal-title":"Aids"},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-3083.1993.tb01711.x","article-title":"Evidence for the role of cr1 (cd35), in addition to cr2 (cd21), in facilitating infection of human t cells with opsonized hiv","volume":"38","author":"Delibrias","year":"1993","journal-title":"Scand. J. Immunol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.4049\/jimmunol.166.5.3410","article-title":"C5a and c5a(desarg) enhance the susceptibility of monocyte-derived macrophages to hiv infection","volume":"166","author":"Kacani","year":"2001","journal-title":"J. Immunol."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JVI.76.7.3179-3188.2002","article-title":"Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons","volume":"76","author":"Speth","year":"2002","journal-title":"J. Virol."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.4049\/jimmunol.173.6.4236","article-title":"Complement mediates the binding of hiv to erythrocytes","volume":"173","author":"Horakova","year":"2004","journal-title":"J. Immunol."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm0296-153","article-title":"A \u201ccomplement-ary\u201d aids vaccine","volume":"2","author":"Dierich","year":"1996","journal-title":"Nat. Med."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1084\/jem.182.2.501","article-title":"Role of virion-associated glycosylphosphatidylinositol-linked proteins cd55 and cd59 in complement resistance of cell line-derived and primary isolates of hiv-1","volume":"182","author":"Saifuddin","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1172\/JCI118190","article-title":"Antibody-dependent complement-mediated cytotoxicity in sera from patients with hiv-1 infection is controlled by cd55 and cd59","volume":"96","author":"Schmitz","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.183.1.307","article-title":"Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor h and decay accelerating factor (daf, cd55)","volume":"183","author":"Stoiber","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_316","doi-asserted-by":"crossref","unstructured":"Xu, J., Lupu, F., and Esmon, C.T. (2010). Inflammation, innate immunity and blood coagulation. Hamostaseologie, 30.","DOI":"10.1055\/s-0037-1617146"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cis406","article-title":"Hiv status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_318","doi-asserted-by":"crossref","unstructured":"Duprez, D.A., Neuhaus, J., Kuller, L.H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H.C., Ledergerber, B., and Lundgren, J. (2012). Inflammation, coagulation and cardiovascular disease in hiv-infected individuals. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044454"},{"key":"ref_319","doi-asserted-by":"crossref","unstructured":"Kuller, L.H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H.C., Ledergerber, B., Lundgren, J., Neuhaus, J., and Nixon, D. (2008). Inflammatory and coagulation biomarkers and mortality in patients with hiv infection. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050203"},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with hiv infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble cd14 independently predict mortality in hiv infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic hiv infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat. Med."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"Cd4+ t cell depletion during all stages of hiv disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-03-414706","article-title":"Coagulation biomarkers predict disease progression in siv-infected nonhuman primates","volume":"120","author":"Pandrea","year":"2012","journal-title":"Blood"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic hiv infection: Relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"e000264","DOI":"10.1161\/JAHA.113.000264","article-title":"Hiv replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation","volume":"2","author":"Baker","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJM196509302731407","article-title":"Isolation of coxsackie virus group a, type 4, from a patient with hemolytic-uremic syndrome","volume":"273","author":"Glasgow","year":"1965","journal-title":"N. Engl. J. Med."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/127.6.698","article-title":"Coxsackie virus group b infections and the hemolytic-uremic syndrome","volume":"127","author":"Austin","year":"1973","journal-title":"J. Infect. Dis."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00467-002-0966-3","article-title":"Role of non-polio enterovirus infection in pediatric hemolytic uremic syndrome","volume":"17","author":"Gianviti","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/000992288001900207","article-title":"The hemolytic uremic syndrome associated with echo 22 infection","volume":"19","author":"Robitaille","year":"1980","journal-title":"Clin. Pediatr."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archpedi.1971.02110050088010","article-title":"Hemolytic-uremic syndrome and myocarditis. Association with coxsackievirus b infection","volume":"122","author":"Ray","year":"1971","journal-title":"Am. J. Dis. Child."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.46.3.378","article-title":"Enteroviruses associated with the hemolytic-uremic syndrome","volume":"46","author":"Ray","year":"1970","journal-title":"Pediatrics"},{"key":"ref_333","first-page":"369","article-title":"Familial hemolytic-uremic syndrome associated with coxsackie b infection","volume":"20","author":"Vecilla","year":"1984","journal-title":"An. Esp. de Pediatr."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pedneo.2012.10.012","article-title":"Hemolytic uremic syndrome caused by enteroviral infection","volume":"54","author":"Lee","year":"2013","journal-title":"Pediatr. Neonatol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1086\/315210","article-title":"Echoviruses and coxsackie b viruses that use human decay-accelerating factor (daf) as a receptor do not bind the rodent analogues of daf","volume":"181","author":"Spiller","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.166.5.1221","article-title":"The mechanism of action of decay-accelerating factor (daf). Daf inhibits the assembly of c3 convertases by dissociating c2a and bb","volume":"166","author":"Fujita","year":"1987","journal-title":"J. Exp. Med."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1084\/jem.160.5.1558","article-title":"Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (daf) into their membranes","volume":"160","author":"Medof","year":"1984","journal-title":"J. Exp. Med."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4049\/jimmunol.129.1.184","article-title":"Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for c3 convertases of the complement system","volume":"129","author":"Burge","year":"1982","journal-title":"J. Immunol."},{"key":"ref_339","first-page":"485","article-title":"Structure and function of decay accelerating factor cd55","volume":"123","author":"Wang","year":"1994","journal-title":"J. Lab. Clin. Med."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1128\/jvi.71.11.8841-8845.1997","article-title":"Complement component 3 interactions with coxsackievirus b3 capsid proteins: Innate immunity and the rapid formation of splenic antiviral germinal centers","volume":"71","author":"Anderson","year":"1997","journal-title":"J. Virol."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.171.1.438","article-title":"Persistent infection of human microvascular endothelial cells by coxsackie b viruses induces increased expression of adhesion molecules","volume":"171","author":"Zanone","year":"2003","journal-title":"J. Immunol."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"979850","DOI":"10.3389\/fped.2022.979850","article-title":"Case report: Diarrhea-associated hemolytic uremic syndrome in the era of COVID-19","volume":"10","author":"Richardson","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_344","doi-asserted-by":"crossref","unstructured":"Smarz-Widelska, I., Syroka-Glowka, M., Janowska-Jaremek, J., Koziol, M.M., and Zaluska, W. (2022). Atypical hemolytic uremic syndrome after SARS-CoV-2 infection: Report of two cases. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191811437"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"11795565211049897","DOI":"10.1177\/11795565211049897","article-title":"Thrombotic microangiopathy in a severe pediatric case of COVID-19","volume":"15","author":"Dalkiran","year":"2021","journal-title":"Clin. Med. Insights. Pediatr."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_347","first-page":"1","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_348","first-page":"148","article-title":"The lectin pathway of complement and rheumatic heart disease","volume":"2","author":"Beltrame","year":"2014","journal-title":"Front. Pediatr."},{"key":"ref_349","doi-asserted-by":"crossref","unstructured":"Krarup, A., Wallis, R., Presanis, J.S., Gal, P., and Sim, R.B. (2007). Simultaneous activation of complement and coagulation by mbl-associated serine protease 2. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000623"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2741\/4633","article-title":"Procoagulant activity during viral infections","volume":"23","author":"Subramaniam","year":"2018","journal-title":"Front. Biosci."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40001-022-00655-6","article-title":"Major coagulation disorders and parameters in COVID-19 patients","volume":"27","author":"Teimury","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11239-021-02403-9","article-title":"Major bleeding complications in critically ill patients with COVID-19 pneumonia","volume":"52","author":"Godier","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/1\/39\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:42:35Z","timestamp":1760132555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/1\/39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":353,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["biom14010039"],"URL":"https:\/\/doi.org\/10.3390\/biom14010039","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,27]]}}}